Literature DB >> 17516149

Maximizing the value of validation findings to better understand treatment satisfaction issues for diabetes.

Meryl Brod1, Torsten Christensen, Donald Bushnell.   

Abstract

BACKGROUND: Variables associated with treatment satisfaction (TS) can be broadly categorized as precursors, ongoing treatment issues, and treatment outcomes. This study continues the validation process for the Insulin Treatment Satisfaction Questionnaire (ITSQ) while examining relationships between TS and these broader influences.
METHODS: Data (N = 299) were collected in a RCT comparing safety and efficacy of inhaled vs. injectable insulin. Validation examined item and factor characteristics, reliability and validity. Regression analyses examined relationships between overall and domain specific TS and the broader influences.
RESULTS: Patients with less previous or current treatment burden had greater TS (p < 0.001). Gender, injection fear, functioning, age, compliance and glycemic control were differentially related to TS at the beginning and end of study. Baseline satisfaction was predictive of future TS (p < 0.001). When all significant factors were examined together, lower burden with the current treatment and higher satisfaction with previous treatment continued to be key (p < 0.001) while other factors were no longer significant. Validation findings confirmed the ITSQ was psychometrically sound.
CONCLUSION: Over the course of treatment, some factors are associated with TS at treatment start while others are key drivers at treatment end. This suggests that TS is not a static concept.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17516149     DOI: 10.1007/s11136-007-9209-1

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  35 in total

1.  The Problem Areas in Diabetes Scale. An evaluation of its clinical utility.

Authors:  G W Welch; A M Jacobson; W H Polonsky
Journal:  Diabetes Care       Date:  1997-05       Impact factor: 19.112

2.  A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control.

Authors:  J Hans DeVries; Frank J Snoek; Piet J Kostense; Nathalie Masurel; Robert J Heine
Journal:  Diabetes Care       Date:  2002-11       Impact factor: 19.112

Review 3.  Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications.

Authors:  R B Haynes; K A McKibbon; R Kanani
Journal:  Lancet       Date:  1996-08-10       Impact factor: 79.321

4.  A clinical trial of continuous subcutaneous insulin infusion versus multiple daily injections in older adults with type 2 diabetes.

Authors:  William H Herman; Liza L Ilag; Susan L Johnson; Catherine L Martin; Joyce Sinding; Abdulaziz Al Harthi; Cynthia D Plunkett; Frankie B LaPorte; Ray Burke; Morton B Brown; Jeffery B Halter; Philip Raskin
Journal:  Diabetes Care       Date:  2005-07       Impact factor: 19.112

5.  Efficacy and safety of inhaled insulin (exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: results of a 6-month, randomized, comparative trial.

Authors:  Priscilla A Hollander; Lawrence Blonde; Richard Rowe; Adi E Mehta; Joseph L Milburn; Kenneth S Hershon; Jean-Louis Chiasson; Seymour R Levin
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

Review 6.  Responsiveness of the Problem Areas In Diabetes (PAID) questionnaire.

Authors:  G Welch; K Weinger; B Anderson; W H Polonsky
Journal:  Diabet Med       Date:  2003-01       Impact factor: 4.359

7.  Development and validation of the insulin treatment satisfaction questionnaire.

Authors:  Roger T Anderson; Soren E Skovlund; David Marrero; Douglas W Levine; Keith Meadows; Meryl Brod; Rajesh Balkrishnan
Journal:  Clin Ther       Date:  2004-04       Impact factor: 3.393

8.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  The effect of prandial glucose regulation with repaglinide on treatment satisfaction, wellbeing and health status in patients with pharmacotherapy naïve Type 2 diabetes: a placebo-controlled, multicentre study.

Authors:  Per Bech; Robert Moses; Ramón Gomis
Journal:  Qual Life Res       Date:  2003-06       Impact factor: 4.147

10.  Patient satisfaction and glycemic control after 1 year with inhaled insulin (Exubera) in patients with type 1 or type 2 diabetes.

Authors:  Julio Rosenstock; Joseph C Cappelleri; Björn Bolinder; Robert A Gerber
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

View more
  8 in total

1.  Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ).

Authors:  Jörn Moock; Franz Hessel; Diana Ziegeler; Thomas Kubiak; Thomas Kohlmann
Journal:  Patient       Date:  2010-03-01       Impact factor: 3.883

2.  A Pragmatic Clinical Trial to Compare the Real-World Effectiveness of V-Go versus Standard Delivery of Insulin in Patients with Advanced Type 2 Diabetes.

Authors:  Mark J Cziraky; Scott Abbott; Matt Nguyen; Kay Larholt; Elizabeth Apgar; Thomas Wasser; Poul Strange; Leon Shi; H Courtenay Harrison; Beverly Everitt; Lynn Nowak
Journal:  J Health Econ Outcomes Res       Date:  2019-03-27

3.  Psychometric evaluation of a multi-dimensional measure of satisfaction with behavioral interventions.

Authors:  Souraya Sidani; Dana R Epstein; Mary Fox
Journal:  Res Nurs Health       Date:  2017-08-31       Impact factor: 2.228

Review 4.  Burden of treatment for chronic illness: a concept analysis and review of the literature.

Authors:  Adem Sav; Michelle A King; Jennifer A Whitty; Elizabeth Kendall; Sara S McMillan; Fiona Kelly; Beth Hunter; Amanda J Wheeler
Journal:  Health Expect       Date:  2013-01-31       Impact factor: 3.377

5.  A systematic review of patient-reported measures of burden of treatment in three chronic diseases.

Authors:  David T Eton; Tarig A Elraiyah; Kathleen J Yost; Jennifer L Ridgeway; Anna Johnson; Jason S Egginton; Rebecca J Mullan; Mohammad Hassan Murad; Patricia J Erwin; Victor M Montori
Journal:  Patient Relat Outcome Meas       Date:  2013-06-05

6.  Examining the ability to detect change using the TRIM-Diabetes and TRIM-Diabetes Device measures.

Authors:  Meryl Brod; Torsten Christensen; Mette Hammer; Anne K Busk; Donald M Bushnell
Journal:  Qual Life Res       Date:  2011-03-19       Impact factor: 4.147

Review 7.  Measuring the burden of treatment for chronic disease: implications of a scoping review of the literature.

Authors:  Adem Sav; Asiyeh Salehi; Frances S Mair; Sara S McMillan
Journal:  BMC Med Res Methodol       Date:  2017-09-12       Impact factor: 4.615

8.  Studying the Hurdles of Insulin Prescription (SHIP): development, scoring and initial validation of a new self-administered questionnaire.

Authors:  Luc Martinez; Silla M Consoli; Louis Monnier; Dominique Simon; Olivier Wong; Bernard Yomtov; Béatrice Guéron; Khadra Benmedjahed; Isabelle Guillemin; Benoit Arnould
Journal:  Health Qual Life Outcomes       Date:  2007-08-29       Impact factor: 3.186

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.